$9.21
-0.18-1.92%
At close: -
$9.25
0.040.43%
After Hours: 4:28 PM EDT
BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $-0.07 | $-0.06 | -16.7 % |
Q2 | 2024-08-05 | $-0.06 | $-0.17 | 64.7 % |
Q1 | 2024-05-06 | $-0.17 | $-0.21 | 19.1 % |
Q4 | 2024-02-26 | $-0.28 | $-0.24 | -16.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $117.09M | $112.50M | 4.08 % |
Q2 | 2024-08-05 | $109.33M | $98.47M | 11.0 % |
Q1 | 2024-05-06 | $92.76M | $85.60M | 8.37 % |
Q4 | 2024-02-26 | $93.40M | $90.01M | 3.77 % |
BioCryst Pharma (BCRX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $-0.07, which missed the estimate of $-0.06.
The Actual Revenue was $117.1M, which beat the estimate of $112.5M.
Browse earnings estimates, EPS, and revenue on all stocks.